EA014070B1 - Применение растительной композиции для лечения воспалительных нарушений - Google Patents

Применение растительной композиции для лечения воспалительных нарушений Download PDF

Info

Publication number
EA014070B1
EA014070B1 EA200800850A EA200800850A EA014070B1 EA 014070 B1 EA014070 B1 EA 014070B1 EA 200800850 A EA200800850 A EA 200800850A EA 200800850 A EA200800850 A EA 200800850A EA 014070 B1 EA014070 B1 EA 014070B1
Authority
EA
Eurasian Patent Office
Prior art keywords
extract
inflammatory disorder
composition
compound
treatment
Prior art date
Application number
EA200800850A
Other languages
English (en)
Russian (ru)
Other versions
EA200800850A1 (ru
Inventor
Виджей Чаухан
Ашиш СУТХАР
Дхананджай Сапре
Свати Бал-Тембе
Ашок Кумар Гангопадхяй
Аша Кулкарни-Алмеида
Сапна Хасит Парик
Original Assignee
Пирамал Лайф Сайнсиз Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пирамал Лайф Сайнсиз Лимитед filed Critical Пирамал Лайф Сайнсиз Лимитед
Publication of EA200800850A1 publication Critical patent/EA200800850A1/ru
Publication of EA014070B1 publication Critical patent/EA014070B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
EA200800850A 2005-09-30 2006-09-28 Применение растительной композиции для лечения воспалительных нарушений EA014070B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1226MU2005 2005-09-30
US73644305P 2005-11-14 2005-11-14
PCT/IB2006/053540 WO2007036900A2 (en) 2005-09-30 2006-09-28 Herbal composition for inflammatory disorders

Publications (2)

Publication Number Publication Date
EA200800850A1 EA200800850A1 (ru) 2008-10-30
EA014070B1 true EA014070B1 (ru) 2010-08-30

Family

ID=37900158

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200800850A EA014070B1 (ru) 2005-09-30 2006-09-28 Применение растительной композиции для лечения воспалительных нарушений

Country Status (10)

Country Link
US (2) US7635494B2 (https=)
EP (1) EP1931366B1 (https=)
JP (1) JP5331962B2 (https=)
AU (1) AU2006296197B2 (https=)
CA (1) CA2624049C (https=)
EA (1) EA014070B1 (https=)
GE (1) GEP20115332B (https=)
MA (1) MA29890B1 (https=)
PL (1) PL1931366T3 (https=)
WO (1) WO2007036900A2 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009016565A1 (en) * 2007-07-27 2009-02-05 Piramal Life Sciences Limited Tricyclic compounds for the treatment of inflammatory disorders
US8383166B2 (en) * 2007-12-03 2013-02-26 Sequent Scientific Limited Stable hydrophobic topical herbal formulationn
CA2751227C (en) 2009-02-02 2021-10-26 Laila Nutraceuticals Composition from sphaeranthus indicus and garcinia mangostana for the control of metabolic syndrome
WO2012014216A1 (en) * 2010-07-28 2012-02-02 Laila Nutraceuticals 7-hydroxyfrullanolide and its analogs for prevention, control and treatment of metabolic disorders
US10105347B2 (en) 2009-02-02 2018-10-23 Laila Nutraceuticals Sphaeranthus indicus derived ingredients and their compositions for enhancing physical performance and energy levels
WO2011033524A2 (en) 2009-08-04 2011-03-24 Laila Nutraceuticals Agents from ficus hispida for the amelioration of metabolic syndrome and related diseases
WO2011083397A1 (en) * 2010-01-05 2011-07-14 Himalaya Global Holdings Limited Herbal composition for skin disorders
PH12013500451A1 (en) * 2010-09-11 2013-05-20 Laila Nutraceuticals Sphaeranthus indicus derived ingredients and their compositions for enhancing physical performance and energy levels
US8263579B2 (en) * 2011-01-24 2012-09-11 Piramal Healthcare Limited Anti-inflammatory compounds
WO2014064609A2 (en) * 2012-10-23 2014-05-01 Piramal Enterprises Limited HERBAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF TNF-α MEDIATED DISEASES
US10792305B2 (en) 2015-06-23 2020-10-06 Nobilis Therapeutics, Inc. Therapeutic immune modulation using noble gas compositions
BR112018073483B1 (pt) * 2016-05-21 2022-08-23 Laila Impex Suplementos e composições dietéticas para a melhoria do desempenho físico e dos níveis de energia

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006016228A2 (en) * 2004-08-02 2006-02-16 Prashanth Kumar V Cytotoxic peptide alkaloid and pharmaceutical compositions for the treatment of neoplastic diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646687A (en) * 1994-12-29 1997-07-08 Lucent Technologies Inc. Temporally-pipelined predictive encoder/decoder circuit and method
US6204523B1 (en) * 1998-11-06 2001-03-20 Lumileds Lighting, U.S., Llc High stability optical encapsulation and packaging for light-emitting diodes in the green, blue, and near UV range
US6686676B2 (en) * 2001-04-30 2004-02-03 General Electric Company UV reflectors and UV-based light sources having reduced UV radiation leakage incorporating the same
US6989412B2 (en) * 2001-06-06 2006-01-24 Henkel Corporation Epoxy molding compounds containing phosphor and process for preparing such compositions
US6841647B2 (en) * 2001-11-06 2005-01-11 National Starch And Chemical Investment Holding Corporation Fluid resistant silicone encapsulant
US7160972B2 (en) * 2003-02-19 2007-01-09 Nusil Technology Llc Optically clear high temperature resistant silicone polymers of high refractive index
US7261441B2 (en) * 2004-02-27 2007-08-28 Avago Technologies Ecbu Ip (Singapore) Pte. Ltd. LED device and method for directing LED light
US7229934B2 (en) * 2004-10-18 2007-06-12 International Business Machines Corporation Porous organosilicates with improved mechanical properties

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006016228A2 (en) * 2004-08-02 2006-02-16 Prashanth Kumar V Cytotoxic peptide alkaloid and pharmaceutical compositions for the treatment of neoplastic diseases

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ATTA-UR-RAHMAN ET AL. "7 HYDROXYFRULLANOLIDE AN ANTIMICROBIAL SESQUITERPENE LACTONE FROM SPHAERANTHUS-INDICUS LINN", JOURNAL OF CHEMICAL RESEARCH (SYNOPSES), no. 3, 1989, page 68, XP009082614, ISSN: 0308-2342, paragraph [0001]; compound 1 *
BAFNA A.R. ET AL. "Immunomodulatory activity of methanol extract of flower-heads of Sphaeranthus indicus Linn", ARS PHARMACEUTICA 2004 SPAIN, vol. 45, no. 3, 2004, pages 281-291, XP009082652, ISSN: 0004-2927, page 282, right-hand column, paragraph 3, page 283, right-hand column, paragraph 1, page 287, right-hand column, paragraph 2; tab. 1 *
GOGTE M.G. ET AL. "SOME INTERESTING SESQUITERPENOIDS FROM SPHAERANTHUS-INDICUS COMPOSITAE", INDIAN JOURNAL OF CHEMISTRY SECTION B ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY, vol. 25, no. 3, 1986, pages 233-238, XP009082613, ISSN: 0376-4699, page 236, left-hand column, paragraph 6 - right-hand column, paragraph 3; compounds 1, 2 *
JAIN A. ET AL. "Inhibition of Propionibacterium acnes-induced mediators of inflammation by Indian herbs", PHYTOMEDICINE, GUSTAV FISCHER VERLAG, STUTTGART, DE, vol. 10, no. 1, 2003, pages 34-38, XP004957198, ISSN: 0944-7113, abstract, page 36, left-hand column, paragraph 3; tab. 1, 2 *

Also Published As

Publication number Publication date
EP1931366A2 (en) 2008-06-18
PL1931366T3 (pl) 2013-11-29
WO2007036900A3 (en) 2007-08-02
CA2624049A1 (en) 2007-04-05
US7635494B2 (en) 2009-12-22
JP2009510051A (ja) 2009-03-12
AU2006296197A2 (en) 2008-06-05
AU2006296197B2 (en) 2012-08-09
HK1112418A1 (en) 2008-09-05
US20090269427A1 (en) 2009-10-29
MA29890B1 (fr) 2008-10-03
EP1931366B1 (en) 2013-05-29
US20080254157A1 (en) 2008-10-16
WO2007036900A2 (en) 2007-04-05
GEP20115332B (en) 2011-11-25
EA200800850A1 (ru) 2008-10-30
CA2624049C (en) 2016-01-12
AU2006296197A1 (en) 2007-04-05
US8206756B2 (en) 2012-06-26
JP5331962B2 (ja) 2013-10-30

Similar Documents

Publication Publication Date Title
US8206756B2 (en) Herbal composition for inflammatory disorders
KR101285234B1 (ko) 백미 추출물을 포함하는 관절염 예방 및 치료용 조성물
JP2008069143A (ja) 関節リウマチ治療用植物抽出物
ES2426174T3 (es) Composición herbácea para trastornos inflamatorios
AU2022201835B2 (en) Plant extracts enriched with ipolamiide derivatives as immunosuppressants for treating immunological disorders
JP5086805B2 (ja) 「抗ガン性野生チョウセンニンジンの精製エキス調整法及びそのガン融合製剤」
US7862837B2 (en) Herbal composition
KR100372562B1 (ko) 류코트리엔 생성 저해활성을 가지는 정유 성분
KR20000026053A (ko) 류코트리엔 생성 저해활성을 가지는 신이 추출물 및 신이로부터분리한 리그난 화합물
ES2241182T3 (es) Procedimiento de inhibicion de la produccion de citocinas.
KR101606645B1 (ko) 다우리놀 화합물을 유효성분으로 포함하는 면역질환의 예방 및 치료용 조성물
KR20240041837A (ko) 귤핵 추출물을 포함하는 미세먼지로 유발된 질환의 예방, 개선 또는 치료용 조성물 및 이의 용도
KR20220168960A (ko) 감초 신품종 원감 또는 신원감을 포함하는 알레르기에 치료 및 예방에 효과있는 약제학적 조성물 및 그 치료제
KR101481040B1 (ko) [10]-진저다이온 또는 1-데하이드로-[10]-진저다이온을 포함하는 항 염증용 조성물
HK1112418B (en) Herbal composition for inflammatory disorders
JPH01500037A (ja) Ｋｂｂｌのガン治療用途
Henri et al. Effects of Cola anomala (K. Schum.) water/ethanol pods extract on the inflammation and intestinal secretion in lipopolysaccharide-induced diarrhea.
MX2008004291A (es) Composicion herbaria para trastornos inflamatorios
KR20240003190A (ko) 신주락톤 a를 포함하는 혈관 염증 치료용 조성물
CN112933097A (zh) 医药组合物用于制备促发炎细胞介素抑制剂的用途
JPH09100294A (ja) 血管新生阻害剤
KR20090082002A (ko) 유비퀴논-9를 함유하는 암 치료 또는 예방용 약제학적조성물
FR2515043A1 (fr) Medicament pour le traitement des maladies provoquees par les virus du groupe de l'herpes

Legal Events

Date Code Title Description
PC4A Registration of transfer of a eurasian patent by assignment
TC4A Change in name of a patent proprietor in a eurasian patent
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM

NF4A Restoration of lapsed right to a eurasian patent

Designated state(s): AM AZ BY KZ KG TJ TM